Xilong Scientific Co., Ltd. (SHE:002584)

Xilong Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	605.76	593.21	559.89	691.01	769.86	724.8
Trading Asset Securities	-	0.11	-	299.65	61.44	153
Cash & Short-Term Investments	605.76	593.32	559.89	990.66	831.3	877.8
Cash Growth	27.79%	5.97%	-43.48%	19.17%	-5.30%	-27.89%
Accounts Receivable	1,719	1,666	1,637	1,450	1,189	1,271
Other Receivables	61.06	65.48	83.99	278.16	520.58	31.22
Receivables	1,780	1,732	1,721	1,728	1,709	1,302
Inventory	694.05	620.3	561.66	508.2	454.42	713.34
Prepaid Expenses	-	0.01	0.03	0.67	0.2	0.08
Other Current Assets	342.88	342.29	486.84	460.11	704.38	401.34
Total Current Assets	3,422	3,288	3,329	3,688	3,699	3,295
Property, Plant & Equipment	828.7	827.54	845.7	691.6	489.93	513.13
Long-Term Investments	353.17	361.88	369.85	368.41	152.05	145.86
Goodwill	-	-	-	6.54	375.3	375.3
Other Intangible Assets	175.99	180.21	179.43	123.75	62.53	64.47
Long-Term Accounts Receivable	-	2.73	2.73	-	-	-
Long-Term Deferred Tax Assets	17.77	13.87	11.48	12.13	8.13	9.91
Long-Term Deferred Charges	28.47	31.26	9.29	35.43	17.41	11.47
Other Long-Term Assets	14.65	10.31	21.22	54.4	5.6	6.57
Total Assets	4,841	4,716	4,769	4,980	4,810	4,421
Accounts Payable	1,128	988	950.26	1,178	1,362	1,156
Accrued Expenses	9.55	51.98	46.87	53.04	61.17	52.97
Short-Term Debt	641.52	634.51	726.17	750.09	512.1	752.38
Current Portion of Long-Term Debt	112.84	124.06	155.83	66.46	114.27	-
Current Portion of Leases	-	5.85	9.43	1.72	7.11	-
Current Income Taxes Payable	42.56	13.29	5.98	8.28	3.65	31.83
Current Unearned Revenue	62.54	44.03	30.41	41.75	37.01	38.37
Other Current Liabilities	146.17	125.84	144.8	242.8	294.39	120.55
Total Current Liabilities	2,143	1,988	2,070	2,342	2,392	2,152
Long-Term Debt	336.2	375.29	319.09	280.03	94.98	174.91
Long-Term Leases	3.1	3.58	6.05	19.4	14.12	-
Long-Term Unearned Revenue	27.67	27.69	12.87	13.72	2.82	4.04
Long-Term Deferred Tax Liabilities	2.34	2.57	7.2	8.02	-	2.17
Other Long-Term Liabilities	12.43	13.11	-	-	-	-
Total Liabilities	2,525	2,410	2,415	2,663	2,504	2,333
Common Stock	585.22	585.22	585.22	585.22	585.22	585.22
Additional Paid-In Capital	682.38	682.38	682.38	682.38	682.38	669.34
Retained Earnings	997.4	988.76	1,032	999.15	911.06	722.66
Comprehensive Income & Other	44.74	43.4	47.9	43.83	46.91	39.38
Total Common Equity	2,310	2,300	2,348	2,311	2,226	2,017
Minority Interest	6.35	6.03	6.06	5.8	80.81	71.58
Shareholders' Equity	2,316	2,306	2,354	2,316	2,306	2,088
Total Liabilities & Equity	4,841	4,716	4,769	4,980	4,810	4,421
Total Debt	1,094	1,143	1,217	1,118	742.57	927.29
Net Cash (Debt)	-487.9	-549.96	-656.68	-127.04	88.73	-49.49
Net Cash Per Share	-0.81	-0.98	-1.18	-0.21	0.17	-0.09
Filing Date Shares Outstanding	585.22	585.22	585.22	585.22	585.22	585.22
Total Common Shares Outstanding	585.22	585.22	585.22	585.22	585.22	585.22
Working Capital	1,279	1,300	1,260	1,345	1,307	1,143
Book Value Per Share	3.95	3.93	4.01	3.95	3.80	3.45
Tangible Book Value	2,134	2,120	2,169	2,180	1,788	1,577
Tangible Book Value Per Share	3.65	3.62	3.71	3.73	3.05	2.69
Buildings	-	587.12	596.4	472.95	447.59	452.04
Machinery	-	393.87	241.28	205.2	176.27	197.38
Construction In Progress	-	68.24	207.89	185.53	12.77	41.36

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.